Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

NCT00535119 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

107

Enrollment

NIH

Sponsor class

Conditions

Adult Solid Neoplasm
BRCA1 Mutation Carrier
BRCA2 Mutation Carrier
Hereditary Breast and Ovarian Cancer Syndrome

Interventions

DRUG: Carboplatin
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
OTHER: Pharmacological Study
DRUG: Veliparib

Sponsor

National Cancer Institute (NCI)